Dare Bioscience Inc. (DARE)

Business: Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States.

IPO Date: 10-Apr-2014

Pres, CEO, Sec. & Director: Ms. Sabrina Martucci Johnson

Chief Financial Officer: Ms. Lisa Walters-Hoffert

Listing: NASDAQ: DARE

Country: United States

Headquarters: San Diego, CA

Website: https://www.darebioscience.com

Market cap: $116.90 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-39.77 Mln

Cash: $39.32 Mln

Total Debt: $1.21 Mln

Insider's Holding: 1.96%

Liquidity: Low

52 Week range: $0.92 - 2.51

Shares outstanding: 84,711,296

10 Years Aggregate:

• CFO: $-28,937.53 Mln
• EBITDA: $-66,604.95 Mln
• Net Profit: $-66,280.84 Mln